Elizaveta V. Pankratova

Elizaveta V. Pankratova


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2016 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
EPElizaveta V. Pankratova
Elizaveta V. Pankratova
ASAlexander G. Stepchenko
Alexander G. Stepchenko
TPTatiana Portseva
Tatiana Portseva
VMVladic Mogila
Vladic Mogila
SGSofia G. Georgieva
Sofia G. Georgieva
Oct-1 transcription factor has various functions in gene regulation. Its expression level is increased in several types of cancer and is associated with poor survival prognosis. Here we identified distinct Oct-1 protein isoforms in human cells and compared gene expression patterns and functions for Oct-1A, Oct-1L, and Oct-1X isoforms that differ by their N-terminal sequences. The longest isoform, Oct-1A, is abundantly expressed and is the main Oct-1 isoform in most of human tissues. The Oct-1L and the weakly expressed Oct-1X regulate the majority of Oct-1A targets as well as additional sets of genes. Oct-1X controls genes involved in DNA replication, DNA repair, RNA processing, and cellular response to stress. The high level of Oct-1 isoforms upregulates genes related to cell cycle progression and activates proliferation both in Namalwa Burkitt's lymphoma cells and primary human fibroblasts. It downregulates expression of genes related to antigen processing and presentation, cytokine-cytokine receptor interaction, oxidative metabolism, and cell adhesion, thus facilitating pro-oncogenic processes.

6 July 2018 in Oncotarget
Verified
Journal Article
Open access
PDF file
EPElizaveta V. Pankratova
Elizaveta V. Pankratova
ASAlexander G. Stepchenko
Alexander G. Stepchenko
IKIrina D. Krylova
Irina D. Krylova
TPTatiana N. Portseva
Tatiana N. Portseva
SGSofia G. Georgieva
Sofia G. Georgieva
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Elizaveta V. Pankratova1, *, Alexander G. Stepchenko1, *, Irina D. Krylova1, Tatiana N. Portseva1, 2 and Sofia G. Georgieva1 1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia 2Pirogov Russian National Research Medical University, Moscow, Russia *These authors have contributed equally to the work Correspondence to: Sofia G. Georgieva, email: sonjag@molbiol.edu.ru Elizaveta V. Pankratova, email: pank@eimb.ru Keywords: POU2F1; isoforms; hematopoietic cells differentiation; molecular therapeutic target Abbreviations: POU2F1, POU domain class 2 transcription factor 1 Received: April 01, 2018 Accepted: May 31, 2018 Published: July 06, 2018 ABSTRACT Oct-1(POU2F1) is a DNA-binding transcription regulator and its level being highly increased in many human cancers. Oct-1 is present in the human cells as a family of functionally different isoforms which are transcribed from alternative promoters. Here, we have demonstrated that expression patterns of Oct-1 isoforms change during differentiation of hematopoetic progenitor cells (CD34+) (HPCs) to the B (CD19+) and T (CD3+) cells. While Oct-1L is expressed at a high level in the CD34+ HPCs, its expression level drops dramatically during the T-cell differentiation, although remains nearly the same in B-cells. We have described the novel human Oct-1R isoform which is conserved in mammals and is B cell-specific. Oct-1R was found in B cells, but not in HPCs. Oct-1R is transcribed from the same promoter as Oct-1L, another lymphocyte-specific isoform. Overexpression of Oct-1R and Oct-1L in the Namalwa cells leads to the repression of many genes involved in B-lymphocyte differentiation and signal transduction. Thus these isoforms may regulate the particular stages of development of normal B cells and maintain their proper differentiation status. However the extremely high level of Oct-1L isoform observed in the B-lymphoblast tumor cell lines indicated that the excess of Oct-L seem likely to considerably decrease the differentiation ability of these cells. Oct-1 may serve as a therapeutic target for many tumors, but it should be noted that in a tumor the content of a certain isoform Oct-1, rather than the total Oct-1 protein, can be increased.

31 October 2006 in Biochimie
Verified
Journal Article
Closed access
EPElizaveta V. Pankratova
Elizaveta V. Pankratova
ESE. Sytina
E. Sytina
OPO. Polanovsky
O. Polanovsky

22 September 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ASAlexander G. Stepchenko
Alexander G. Stepchenko
TPTatiana N. Portseva
Tatiana N. Portseva
IGIvan A. Glukhov
Ivan A. Glukhov
AKAlina P. Kotnova
Alina P. Kotnova
BLBella M. Lyanova
Bella M. Lyanova
EPElizaveta V. Pankratova
Elizaveta V. Pankratova
The emergence of new primate-specific genes is an essential factor in human and primate brain development and functioning. POU2F1/Oct-1 is a transcription regulator in higher eukaryotes which is involved in the regulation of development, differentiation, stress response, and other processes. We have demonstrated that the Tigger2 transposon insertion into the POU2F1 gene which occurred in the primate lineage led to the formation of an additional exon (designated the Z-exon). Z-exon-containing primate-specific Oct-1Z transcript includes a short upstream ORF (uORF) located at its 5’-end and the main ORF encoding the Oct-1Z protein isoform (Pou2F1 isoform 3, P14859-3), which differs from other Oct-1 isoforms by its N-terminal peptide. The Oct-1Z-encoding transcript is expressed mainly in human brain cortex. Under normal conditions, the translation of the ORF coding for the Oct-1Z isoform is repressed by uORF. Under various stress conditions, uORF enables a strong increase in the translation of the Oct-1Z-encoding ORF. Increased Oct-1Z expression levels in differentiating human neuroblasts activate genes controlling stress response, neural cell differentiation, brain formation, and organogenesis. We have shown that the Oct-1Z isoform of the POU2F1/Oct-1 transcription factor is an example of a primate-specific genomic element contributing to brain development and cellular stress defense.

1 July 2013 in Molecular Biology
Verified
Journal Article
Closed access
PDF file
IKI. D. Krylova
I. D. Krylova
TPT. N. Portseva
T. N. Portseva
SGS. G. Georgieva
S. G. Georgieva
ASA. G. Stepchenko
A. G. Stepchenko
EPElizaveta V. Pankratova
Elizaveta V. Pankratova
The Oct-1 transcription factor belongs to a family of highly conserved POU domain proteins that participate in the regulation of housekeeping and tissue-specific gene expression. Several isoforms of Oct-1 were described previously. We have found the new alternative promoter of Oct-1 gene and the corresponding mRNA Oct-1X. This mRNA encodes the alternative Oct-1 isoform, which has a truncated N-terminus compared to Oct-1A or Oct-1L isoforms. We explored the expression pattern of this isoform in human tissues and cell lines and demonstrated that it is ubiquitously expressed, but its expression strongly varies in different tissues. Using cotransfection and double luciferase assay, we have demonstrated that Oct-1X is the activator of housekeeping (histone H2B) and tissue-specific genes (B29) transcription.

1 June 2008 in Molecular Biology
Verified
Journal Article
Closed access
PDF file
EPElizaveta V. Pankratova
Elizaveta V. Pankratova
Many genes are known to have several promoters. The contribution of alternative promoters to the structural and functional diversity of protein isoforms in eukaryotic cells is considered, including their role in synthesis of identical proteins from different mRNAs, generation of protein isoforms with different and even opposite functions, expression of housekeeping genes, and the variation of the recognition domains of adhesion proteins and receptors. In some cases, alternative promoters allow one gene to produce mRNAs with different open reading frames and, consequently, proteins with no amino acid sequence homology.